INTREPID II: International Research Programme on Psychoses In Diverse Settings

INTREPID II is a research programme to study the epidemiology, phenomenology, aetiology and outcome of psychotic disorders in diverse settings. It builds on previously-developed methods for the study of schizophrenia and other psychoses from the INTREPID I pilot study. 

The overall aim of the five-year research programme is to investigate the variability - in incidence, presentation, outcome, and impact - of psychotic disorders in diverse developing countries. The programme takes place in sites in three countries (India, Nigeria, Trinidad) and consists of four inter-connected studies, aiming to:

(1) investigate the incidence and presentation of untreated psychotic disorders in each site and associated risk factors;

(2) investigate the 2-year course and outcome of psychotic disorders and associated factors;

(3) investigate (a) help-seeking and (b) the impact of psychotic disorders on individuals and families, using a combination of quantitative and qualitative approaches;

(4) investigate the types and prevalence of physical health problems and related risk markers.

CGMH Project Team

Professor Craig Morgan, King's College London (Principal Investigator)

Dr Alex Cohen, London School of Hygiene and Tropical Medicine

Professor Helen Weiss,  London School of Hygiene and Tropical Medicine

Tessa Roberts, King's College London

Funder

Medical Research Council 

Project Partners

Schizophrenia Research Foundation (SCARF; Chennai, India)

University of Ibadan (Nigeria)

University of the West Indies (Trinidad)

London School of Hygiene and Tropical Medicine (UK)

Institute of Psychiatry, Psychology & Neuroscience, King's College London (UK)